Cogniwell delivers end-to-end finished formulation manufacturing with precision, scalability, and compliance at its core. From tablet compression to sterile injectables, our state-of-the-art facilities ensure global standards (WHO-GMP, USFDA, EMA) are met seamlessly. Partner with us for agile production, reduced time-to-market, and uncompromised quality—every batch, every time.
In an industry where formulation defects account for 30% of regulatory rejections (per FDA 2023 data), Cogniwell’s integrated manufacturing ecosystem eliminates bottlenecks. We specialize in:
Unlike traditional CMOs, our closed-loop digitization (via IoT-enabled equipment) reduces batch deviations by 25%, while our flexible capacity (from pilot to commercial scales) lets you pivot without requalification delays. Benchmark: Our audit-ready documentation system outperforms industry medians in inspection turnaround time by 50% (vs. Catalent/Lonza).
Your Benefit: Faster scale-up, 99.8% right-first-time batches, and a partner who embeds compliance into every step—not as a checkpoint, but as a culture.